The advisory board members bolster the Vvital team to develop a game-changing mitral valve repair solution Misgav, Israel – 24 November 2020 – Vvital Biomed (“Vvital”), a portfolio company of The Trendlines Group Ltd. (SGX: 42T; OTCQX: TRNLY), a leading Israel- and Singapore-based investment group focused on high-growth medical and […]
Other News
CardiacVascularNews talks remote case support and Thanksgiving with Jenn Fried, CEO of ExplorerSurgical.
Listen to Jenn Fried, CEO of Explorer Surgical talk about the move to digital, remote case support, workflows, and what’s on her table this year for Thanksgiving.
Rapid Medical Expands Comaneci™ CE Mark Indication to Include Vasospasm Treatment
Comaneci is the first adjustable mesh device indicated for the endovascular treatment of vasospasm YOKNEAM, Israel, Nov. 23, 2020 /PRNewswire/ — Rapid Medical, a company focused on the development of next-generation neurovascular devices, has announced CE Mark approval for the expanded indication of Comaneci to treat cerebral vasospasm. Comaneci is the first adjustable remodeling […]
FDA Clears First of its Kind Algorithm Suite for Personal ECG
AliveCor Paving the Way For A New Generation of AI-Powered Remote Cardiology MOUNTAIN VIEW, Calif., Nov. 23, 2020 /PRNewswire/ — AliveCor, the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions, today announced that the US FDA had given clearance to the company’s next generation of interpretive ECG algorithms. “Kardia […]
Inovytec and Israel Defense Forces Partner to Advance Military Ventilator Capabilities
Inovytec’s Ventway Sparrow Increases Mobility while Maintaining High-Performance Ventilation, Making it Ideal for Soldiers in the Field RA’ANANA, Israel, Nov. 23, 2020 /PRNewswire/ — Inovytec, a developer of cutting-edge, first-line respiratory and cardiac medical solutions, announced today that the Ventway Sparrow (Ventway) MIL Standard model, a lightweight tactical ventilator, has been deployed by the Israel Defense […]
Amgen To Transition Development And Commercial Rights For Omecamtiv Mecarbil And AMG 594 To Cytokinetics
THOUSAND OAKS, Calif., Nov. 23, 2020 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced the Company has provided notice to Cytokinetics of termination of its collaboration and its intention to transition the development and commercialization rights for omecamtiv mecarbil and AMG 594. Omecamtiv mecarbil, an investigational selective cardiac myosin activator, was studied in GALACTIC-HF, […]
VitalConnect Announces the Launch of VitalPatch® RTM, a First-of-its-kind Extended Holter Technology for Cardiac Monitoring
In combination with its newly opened independent diagnostic testing facility, VitalConnect is advancing how patients are monitored for cardiac arrhythmias SAN JOSE, Calif.–(BUSINESS WIRE)–VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, announced today it has launched its VitalPatch RTM cardiac monitoring solution for patients who require extended Holter […]
Penumbra’s Newest Generation of Indigo Aspiration System Receives FDA Clearance for Pulmonary Embolism
Lightning 12 and Separator 12 Now Indicated for Treatment of PE ALAMEDA, Calif.–(BUSINESS WIRE)–Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration 510(k) clearance for expanded indication of the latest iteration of the Indigo® Aspiration System, Lightning™ 12. As part of […]
GE Healthcare Pioneers Photon Counting CT with Prismatic Sensors Acquisition
GE Healthcare invests in a unique approach to cutting-edge CT technology and acquires Prismatic Sensors AB, a leader in Deep Silicon detector technology for photon counting computed tomography (PCCT) CHICAGO–(BUSINESS WIRE)–GE Healthcare today announced its acquisition of Prismatic Sensors AB, a Swedish start-up specializing in photon counting detectors, signifying the […]
Aziyo Biologics Reports Third Quarter 2020 Financial Results
SILVER SPRING, Md., Nov. 19, 2020 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the three and nine months ended September 30, 2020. Recent […]



